30 likes | 171 Vues
This document outlines the expanded core functions of the RPRGs, including strategic and technical support for the development and review of annual work plans (AWPs), drug requests, and monitoring and evaluation (M&E) activities. The focus is on scaling up or down LF MDA and STH PC interventions, as well as preparing elimination dossiers for all preventive chemotherapy (PC) diseases. Collaboration with NTD partners and technical support for national programs, including advice on programmatic decisions, is emphasized to ensure effective disease management and stakeholder engagement.
E N D
Expanding RPRGs Minimum core functions: • Technical/managerial support for review and development of the annual work plans (AWP), drug requests, M&E activities, scaling up/down LF MDA, scaling up STH PC, and preparation of elimination dossier, for all PC diseases >> to be coordinated with NTD partners • Strategic advice on programmatic decisions for all PC diseases (TAS eligibility, stop-MDA, deworming frequency etc.) >> identify issues to be referred back to NTD STAG and its WGs
Proposed interaction and technical support for the national programmes NTD STAG WGs and Sub-WGs MEC MAC WHO RPRGs TEC MOH